Commonwealth Equity Services’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$818K Buy
39,844
+11,648
+41% +$267K ﹤0.01% 2877
2026
Q1
$621K Sell
28,196
-1,699
-6% -$29.6K ﹤0.01% 3017
2025
Q4
$352K Sell
29,895
-6,128
-17% -$78.7K ﹤0.01% 3512
2025
Q3
$571K Buy
36,023
+7,214
+25% +$105K ﹤0.01% 3068
2025
Q2
$330K Sell
28,809
-4,577
-14% -$51.6K ﹤0.01% 3501
2025
Q1
$452K Sell
33,386
-18,565
-36% -$308K ﹤0.01% 3107
2024
Q4
$878K Sell
51,951
-8,352
-14% -$162K ﹤0.01% 2493
2024
Q3
$1.23M Sell
60,303
-10,320
-15% -$211K ﹤0.01% 2183
2024
Q2
$1.59M Sell
70,623
-3,997
-5% -$105K ﹤0.01% 1941
2024
Q1
$1.96M Buy
74,620
+2,010
+3% +$57.3K ﹤0.01% 1800
2023
Q4
$2.29M Sell
72,610
-5,007
-6% -$136K ﹤0.01% 1604
2023
Q3
$2.18M Buy
77,617
+1,360
+2% +$46.7K ﹤0.01% 1556
2023
Q2
$2.81M Sell
76,257
-2,569
-3% -$78.4K 0.01% 1395
2023
Q1
$2.36K Buy
78,826
+440
+0.6% +$14.5K 0.01% 1462
2022
Q4
$2.4M Sell
78,386
-61,367
-44% -$1.84M 0.01% 1386
2022
Q3
$3.44M Buy
139,753
+15,745
+13% +$519K 0.01% 1093
2022
Q2
$3.97M Buy
124,008
+11,701
+10% +$430K 0.01% 1008
2022
Q1
$3.54M Sell
112,307
-20,394
-15% -$638K 0.01% 1153
2021
Q4
$4.45M Buy
132,701
+23,458
+21% +$731K 0.01% 987
2021
Q3
$3.17M Buy
109,243
+4,146
+4% +$134K 0.01% 1142
2021
Q2
$3.66M Buy
105,097
+29,731
+39% +$985K 0.01% 1035
2021
Q1
$2.1M Sell
75,366
-3,014
-4% -$80.2K 0.01% 1284
2020
Q4
$1.94M Buy
78,380
+702
+0.9% +$16.7K 0.01% 1254
2020
Q3
$1.62M Sell
77,678
-2,440
-3% -$47.1K 0.01% 1209
2020
Q2
$1.23M Buy
80,118
+23,831
+42% +$301K ﹤0.01% 1290
2020
Q1
$499K Buy
56,287
+6,027
+12% +$86.9K ﹤0.01% 1693
2019
Q4
$909K Buy
50,260
+5,408
+12% +$89.8K ﹤0.01% 1486
2019
Q3
$670K Buy
44,852
+4,329
+11% +$70.4K ﹤0.01% 1613
2019
Q2
$972K Sell
40,523
-1,789
-4% -$52.7K ﹤0.01% 1358
2019
Q1
$1.57M Buy
42,312
+4,699
+12% +$171K 0.01% 1036
2018
Q4
$1.06M Sell
37,613
-5,575
-13% -$176K 0.01% 1169
2018
Q3
$1.7M Buy
43,188
+1,277
+3% +$55.9K 0.01% 1004
2018
Q2
$1.86M Buy
41,911
+846
+2% +$42.1K 0.01% 931
2018
Q1
$2M Buy
41,065
+2,990
+8% +$149K 0.01% 868
2017
Q4
$1.91M Buy
38,075
+368
+1% +$19.3K 0.01% 877
2017
Q3
$1.91M Buy
37,707
+1,974
+6% +$93.1K 0.01% 824
2017
Q2
$1.35M Buy
35,733
+790
+2% +$31.2K 0.01% 994
2017
Q1
$1.34M Buy
34,943
+640
+2% +$19.3K 0.01% 964
2016
Q4
$758K Buy
34,303
+5,226
+18% +$107K 0.01% 1171
2016
Q3
$465K Sell
29,077
-6,069
-17% -$69.3K ﹤0.01% 1424
2016
Q2
$290K Sell
35,146
-7,649
-18% -$68.2K ﹤0.01% 1684
2016
Q1
$300K Buy
42,795
+4,482
+12% +$22.5K ﹤0.01% 1636
2015
Q4
$205K Sell
38,313
-5,041
-12% -$32.2K ﹤0.01% 1863
2015
Q3
$281K Buy
+43,354
New +$454K ﹤0.01% 1591

Other funds holding CC

Commonwealth Equity Services's CC Position: Q2 2026 in Review

Commonwealth Equity Services increased its Chemours (CC) stake by 41% in Q2 2026, buying an estimated $267K and bringing the position to 39,844 shares worth $818K. The position accounts for ﹤0.01% of the portfolio, ranked #2877.

Commonwealth Equity Services first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $4.45M in Q4 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Commonwealth Equity Services held 39,844 shares of Chemours worth $818K as of Q2 2026.
  • Commonwealth Equity Services bought 11,648 Chemours shares in Q2 2026, an estimated $267K.
  • Chemours made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2877 holding.
  • Commonwealth Equity Services first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
  • Commonwealth Equity Services's Chemours position peaked at $4.45M in Q4 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.